Latest

It is unclear how aggressively Congress will reassess a bill that passed last year with no opposition.

  • Oct 17, 2017

Rep. Judy Chu also called for an investigation into whether the law is harming enforcement against “bad actors.”

  • Oct 17, 2017

Rep. Tom Marino (R-Pa.) was under fire in the wake of revelations in a Washington Post/“60 Minutes” investigation that the lawmaker helped steer legislation in Congress making it harder for the DEA to act against giant drug companies.

  • Oct 17, 2017

The president’s comments came as Democrats reacted sharply to the report that found the lawmaker helped steer legislation that made it harder for the government to take some enforcement actions against giant drug companies.

  • Oct 16, 2017

The new law undermined the DEA’s efforts to stanch the flow of pain pills as the opioid crisis worsened.

  • Oct 16, 2017

At the DEA, Rannizzisi promoted tough enforcement until Congress and the industry pushed back.

  • Oct 15, 2017

The Pennsylvania congressman from an opioid-ravaged district is a big defender of drug companies.

  • Oct 15, 2017

  • Oct 15, 2017

The $35 million deal with Mallinckrodt Pharmaceuticals requires the company to take further steps in reporting suspicious orders of its drugs.

  • Jul 11, 2017

After years of government and pharmaceutical firms failing to control the problem, some lawyers say the suits have the potential to force the industry to curb practices that contribute to it.

  • Jul 4, 2017
Load More